Literature DB >> 21784828

The microvasculature in chronic kidney disease.

Qi Lun Ooi1, Foong Kien Newk-Fon Hey Tow, Raj Deva, Mohamad Afzal Alias, Ryo Kawasaki, Tien Y Wong, Nor Mohamad, Deb Colville, Anastasia Hutchinson, Judy Savige.   

Abstract

BACKGROUND AND OBJECTIVES: Individuals with chronic kidney disease (CKD) stages 3 to 5 have an increased risk of cardiac and other vascular disease. Here we examined the association of CKD 3 to 5 with small vessel caliber. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a cross-sectional observational study of 126 patients with CKD stages 3 to 5 (estimated GFR [eGFR] <60 ml/min per 1.73 m(2)) and 126 age- and gender-matched hospital patients with CKD 1 or 2. Retinal vessel diameters were measured from digital fundus images by a trained grader using a computer-assisted method and summarized as the central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE).
RESULTS: Patients with CKD 3 to 5 had a smaller mean CRAE and CRVE than hospital controls (139.4 ± 17.8 μm versus 148.5 ± 16.0 μm, P < 0.001; and 205.0 ± 30.7 μm versus 217.4 ± 25.8 μm, respectively; P = 0.001). CRAE and CRVE decreased progressively with each stage of renal failure CKD1-2 to 5 (P for trend = 0.08 and 0.04, respectively). CKD and hypertension were independent determinants of arteriolar narrowing after adjusting for age, gender, diabetes, dyslipidemia, and smoking history. Patients with CKD 5 and diabetes had a larger mean CRAE and CRVE than nondiabetics (141.4 ± 14.9 μm versus 132.9 ± 14.2 μm; 211.1 ± 34.4 μm versus 194.8 ± 23.8 μm).
CONCLUSIONS: The microvasculature is narrowed in patients with reduced eGFR.

Entities:  

Mesh:

Year:  2011        PMID: 21784828      PMCID: PMC3359539          DOI: 10.2215/CJN.10291110

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  39 in total

Review 1.  Role of the microvascular endothelium in progressive renal disease.

Authors:  Duk-Hee Kang; John Kanellis; Christian Hugo; Luan Truong; Sharon Anderson; Dontscho Kerjaschki; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  Microvascular disease--the Cinderella of uraemic heart disease.

Authors:  K Amann; E Ritz
Journal:  Nephrol Dial Transplant       Date:  2000-10       Impact factor: 5.992

4.  Revised formulas for summarizing retinal vessel diameters.

Authors:  Michael D Knudtson; Kristine E Lee; Larry D Hubbard; Tien Yin Wong; Ronald Klein; Barbara E K Klein
Journal:  Curr Eye Res       Date:  2003-09       Impact factor: 2.424

5.  Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes.

Authors:  Tien Yin Wong; Anoop Shankar; Ronald Klein; Barbara E K Klein
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

6.  Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.

Authors:  B F Culleton; M G Larson; P W Wilson; J C Evans; P S Parfrey; D Levy
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

7.  Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; Bruce B Duncan; David J Couper; James M Tielsch; Barbara E K Klein; Larry D Hubbard
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

8.  Retinal microvascular caliber and chronic kidney disease in an Asian population.

Authors:  Charumathi Sabanayagam; Anoop Shankar; David Koh; Kee Seng Chia; Seang Mei Saw; Su Chi Lim; E Shyong Tai; Tien Yin Wong
Journal:  Am J Epidemiol       Date:  2008-12-16       Impact factor: 4.897

Review 9.  Tubulointerstitial disease: role of ischemia and microvascular disease.

Authors:  Takahiko Nakagawa; Duk-Hee Kang; Ryuji Ohashi; Shin-ichi Suga; Jaime Herrera-Acosta; Bernardo Rodriguez-Iturbe; Richard J Johnson
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-05       Impact factor: 2.894

10.  Hypertensive retinopathy and incident coronary heart disease in high risk men.

Authors:  B B Duncan; T Y Wong; H A Tyroler; C E Davis; F D Fuchs
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

View more
  24 in total

1.  Assessment of ocular microcirculation in patients with end-stage kidney disease.

Authors:  Tetsushi Arimura; Tomoaki Shiba; Mao Takahashi; Shun Kumashiro; Hironori Osamura; Tadashi Matsumoto; Ken Sakai; Yuichi Hori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-10       Impact factor: 3.117

2.  Association Between Progression of Retinopathy and Concurrent Progression of Kidney Disease: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Ebenezer Daniel; Maureen Maguire; Dawei Xie; Jason Roy; Revell Whittock-Martin; Candace Parker Ostroff; Joan C Lo; Raymond R Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold I Feldman; John W Kusek
Journal:  JAMA Ophthalmol       Date:  2019-07-01       Impact factor: 7.389

3.  Retinopathy and progression of CKD: The CRIC study.

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Ebenezer Daniel; Maureen G Maguire; Dawei Xie; Revell Whittock-Martin; Candace Parker Ostroff; Joan C Lo; Raymond R Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold I Feldman; John W Kusek
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 8.237

4.  The relationship of renal function to segmental vascular stiffness, ankle-brachial index, and peripheral artery disease.

Authors:  Yueh-Hung Lin; Kuo-Tzu Sung; Cheng-Ting Tsai; Pei-Chen Wu; Yau-Huei Lai; Chi-In Lo; Fa-Chang Yu; Hsu-Ping Wu; Wei-Ran Lan; Jen-Yuan Kuo; Charles Jia-Yin Hou; Chi-Hsuan Yen; Ming-Cheng Peng; Ta-Chuan Hung; Chung-Lieh Hung; Edward Lai; Hung-I Yeh
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-11       Impact factor: 3.738

5.  Super-resolution ultrasound localization microscopy based on a high frame-rate clinical ultrasound scanner: an in-human feasibility study.

Authors:  Chengwu Huang; Wei Zhang; Ping Gong; U-Wai Lok; Shanshan Tang; Tinghui Yin; Xirui Zhang; Lei Zhu; Maodong Sang; Pengfei Song; Rongqin Zheng; Shigao Chen
Journal:  Phys Med Biol       Date:  2021-04-08       Impact factor: 3.609

6.  Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.

Authors:  Rajesh Mohandas; Mark S Segal; Tianyao Huo; Eileen M Handberg; John W Petersen; B Delia Johnson; George Sopko; C Noel Bairey Merz; Carl J Pepine
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

7.  Bronchial asthma is associated with increased risk of chronic kidney disease.

Authors:  Hui-Ling Huang; Shinn-Ying Ho; Chien-Hsun Li; Fang-Ying Chu; Li-Ping Ciou; Hua-Chin Lee; Wen-Liang Chen; Nian-Sheng Tzeng
Journal:  BMC Pulm Med       Date:  2014-05-08       Impact factor: 3.317

8.  Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease.

Authors:  Dorothea Burkhardt; Maria Bartosova; Betti Schaefer; Niels Grabe; Bernd Lahrmann; Hamoud Nasser; Christian Freise; Axel Schneider; Anja Lingnau; Petra Degenhardt; Bruno Ranchin; Peter Sallay; Rimante Cerkauskiene; Michal Malina; Gema Ariceta; Claus Peter Schmitt; Uwe Querfeld
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

Review 9.  Hypertension in pediatric patients with chronic kidney disease: management challenges.

Authors:  Claire M Gallibois; Natasha A Jawa; Damien G Noone
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-07-26

10.  Relationship between retinal blood flow and renal function in patients with type 2 diabetes and chronic kidney disease.

Authors:  Taiji Nagaoka; Akitoshi Yoshida
Journal:  Diabetes Care       Date:  2012-11-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.